Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 17.88
  • Annual Dividend & Yield 0.14 (0.15%)
  • Most Recent Dividend 0.015 on 09/23/24
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 27.25% ( -0.73%)
  • Historical Volatility 26.19%
  • IV Percentile 32%
  • IV Rank 28.06%
  • IV High 38.19% on 08/05/24
  • IV Low 22.98% on 11/12/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 119
  • Volume Avg (30-Day) 71,927
  • Put/Call OI Ratio 1.06
  • Today's Open Interest 917,775
  • Open Int (30-Day) 863,539

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.67 +3.03%
on 11/19/24
105.47 -11.43%
on 11/11/24
-4.73 (-4.82%)
since 10/21/24
3-Month
90.67 +3.03%
on 11/19/24
105.47 -11.43%
on 11/11/24
-8.40 (-8.25%)
since 08/21/24
52-Week
71.99 +29.77%
on 11/27/23
105.47 -11.43%
on 11/11/24
+21.42 (+29.75%)
since 11/21/23

Most Recent Stories

More News
5 Stocks Retail Investors Are Most Bearish On At Mid-Day

Disappointing retail earnings and concerns about bloated valuations are weighing down on retail sentiment toward some stocks.

WSM : 170.52 (-2.58%)
MSTR : 513.27 (+8.32%)
XP : 15.76 (+0.57%)
LCTX : 0.6036 (-5.89%)
SPY : 591.33 (+0.14%)
ELF : 119.49 (+0.41%)
XBI : 93.67 (-0.36%)
5 Stocks Retail Investors Are Most Bullish On At Mid-Day

Retailers went overboard about a couple of biotech stocks and a MedTech name, among others on Wednesday.

FBRX : 11.20 (-17.34%)
QSI : 1.2300 (-11.51%)
DUOT : 5.16 (-0.77%)
IBB : 134.67 (-0.13%)
SLXN : 0.2420 (-27.35%)
SPY : 591.33 (+0.14%)
XBI : 93.67 (-0.36%)
ZIM : 23.98 (-11.22%)
5 Top-Ranked ETFs to Buy on the Dip

After the best week of 2024 on excitement over President-elect Trump’s policies, Wall Street lost momentum last week on sticky inflation and the Fed’s hawkish comments. The S&P 500 dropped more than...

MISL : 31.72 (+0.51%)
QTEC : 193.46 (+0.55%)
XSD : 233.38 (+1.07%)
IDGT : 77.83 (+0.33%)
XBI : 93.67 (-0.36%)
Trump Names Anti-Vaxxer Robert Kennedy As Health & Human Services Secretary: Here’s What It Means For Healthcare Stocks

Trump said his HHS Secretary nominee will ensure the public is protected from harmful substances that have aggravated the nation’s health crisis.

NVO : 102.62 (-2.52%)
IBB : 134.67 (-0.13%)
LLY : 740.66 (-1.69%)
MRNA : 36.58 (-0.97%)
AMGN : 286.19 (-0.58%)
XBI : 93.67 (-0.36%)
PFE : 24.84 (-0.40%)
BNTX : 102.38 (+0.23%)
SNY : 47.72 (-0.13%)
Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with Disruptive Approaches to Treating Alzheimer’s Alzheimer’s...

ANVS : 6.45 (-1.38%)
LLY : 740.66 (-1.69%)
INMB : 4.57 (+0.33%)
XBI : 93.67 (-0.36%)
BIIB : 155.62 (-0.24%)
SAVA : 26.87 (+3.15%)
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.

ALDX : 4.73 (-0.63%)
STIM : 0.7840 (-2.31%)
PGY : 8.86 (+1.03%)
QSI : 1.2300 (-11.51%)
MNOV : 1.9600 (+0.51%)
AXSM : 94.83 (+0.24%)
VSAT : 6.99 (+0.87%)
ZS : 205.75 (+2.39%)
BTM : 1.9300 (-2.53%)
RVPH : 1.1800 (-2.88%)
SPY : 591.33 (+0.14%)
XBI : 93.67 (-0.36%)
Moderna Stock Outlook: Is Wall Street Bullish or Bearish?

Moderna has underperformed the broader market and its peers over the past year, and Wall Street analysts are cautious about the stock’s prospects.

$SPX : 5,901.95 (-0.26%)
MRNA : 36.58 (-0.97%)
XBI : 93.67 (-0.36%)
Altimmune Stock Goes Parabolic Following Q3 Results As CEO Touts 2025 As ‘Transformational Year:’ Retail Upbeat

Altimmune is betting big on its investigational metabolic diseases candidate pemvidutide.

ALT : 8.17 (+1.49%)
XBI : 93.67 (-0.36%)
IWM : 232.63 (+0.74%)
Novavax Stock Slides As 2024 Revenue Cut Offsets Q3 Beat, Dampening Retail Confidence

Novavax CEO John Jacobs said the biopharma is looking to expand beyond COVID-19 and influenza.

NVAX : 8.08 (+0.25%)
IWM : 232.63 (+0.74%)
XBI : 93.67 (-0.36%)
Altimmune Stock Slides After New CFO Appointment, Retail Bulls Eye M&A Potential

The new hire’s background includes CFO roles at several biotech firms acquired in high-profile deals, such as Sirna Therapeutics (acquired by Merck) and ILEX Oncology (acquired by Genzyme).

IWO : 301.73 (+0.78%)
ALT : 8.17 (+1.49%)
IWM : 232.63 (+0.74%)
XBI : 93.67 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 96.42
2nd Resistance Point 95.30
1st Resistance Point 94.65
Last Price 93.67
1st Support Level 92.88
2nd Support Level 91.76
3rd Support Level 91.11

See More

52-Week High 105.47
Last Price 93.65
Fibonacci 61.8% 92.68
Fibonacci 50% 88.73
Fibonacci 38.2% 84.78
52-Week Low 71.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar